Metformin and Ozempic both commonly have digestive side effects, including abdominal pain, heartburn, nausea, vomiting, diarrhea, and constipation
For an injectable peptide, those are not minor concerns
Clinical trials have consistently demonstrated that semaglutide treatment is associated with reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, along with small and sometimes variable changes in high-density lipoprotein cholesterol (HDL-C)
Approaches include redox interactions with high-valent metal ions (like Cu 2 and Fe 3 ), suppression of GSH synthesis using agents such as BSO, the use of nanozymes that mimic enzymatic activity, and direct GSH neutralization through molecular binding [18]
GHS-R1a activation triggers Gq/11 protein coupling, which stimulates phospholipase C, generates IP3 and diacylglycerol, and mobilizes intracellular calcium to drive GH exocytosis from secretory granules
Tracking A1C levels which typically drop 1.2-1.4% with consistent use